Probiotic Effect on Gastrointestinal Symptoms (FLORABIOTIC REFUERZO).

Exclusion Criteria

• •Subjects with relevant functional or structural anomalies of the digestive system, such as malformations, angiodysplasias, active peptic ulcers, chronic inflammatory or malabsorption diseases, hiatal hernia, reflux with medication, helicobacter pylori, celiac disease and other diagnosed intolerances, etc.
• •Subjects with surgical interventions with permanent consequences in the digestive system (for example, gastroduodenostomy).
• •Subjects following treatments that alter gastrointestinal function, either chronically or occasionally.
• •Subjects who are being treated with antibiotics (in order to participate, they do not have to have taken antibiotics during the two months prior to the baseline visit).
• •Subjects with any type of cancer or undergoing treatment for it, or with less than 5 years since its eradication.
• •Subjects with any liver disease (may participate with non-alcoholic fatty liver disease).
• •Subjects with allergy to any component of the product under study.
• •Subjects with a high alcohol intake, more than 14 units/day (women) and 20 units/day (men).
• •Pregnant or breastfeeding women.
• •Subjects who present some type of cognitive and/or psychological impediment.
• •Subjects in whom poor collaboration is expected or with difficulties in following the study procedures.
• •Subjects who work with shift changes that include nights.
• •Subjects who follow any type of supplementation that interferes with the study (example: other probiotics).
• •Subjects who are immersed in a significant lifestyle change.